A procedure has been created that will revolutionize the scientific world, Swiss researchers have produced human heart valves from stem cells (stem cells with the ability to divide without losing their properties, being able to produce specialized cells), obtained from the amniotic fluid that surrounds the baby while it is inside the uterus.
The new technique will be used to produce the valves and implant them later, when the baby is born. These valves are a more reliable, effective and durable option than those that can currently be used and are obtained artificially or through the donation of a corpse. The deficiencies in the heart valves of a future baby can be detected through ultrasound when the 20 weeks of gestation have been completed, the new procedure can help babies (1% of births) who have heart problems by born and that are generally problems that lead to the death of the child.
The new therapy for the treatment of congenital defects has been very well received by the scientific community, especially by the American Heart Association when it was presented before the last conference held last Wednesday.
Each scientific achievement is one more step so that babies with problems are more likely to survive and develop properly. This is great news without a doubt.
